Rhythm Pharmaceuticals (RYTM)
Rhythm Pharmaceuticals (RYTM) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- RYTM last traded at $113.50 on 2026-11-20, -2.83% for the session.
- Rhythm Pharmaceuticals: market cap $7.87B, revenue $280.75M over the last four quarters.
- Over the past year RYTM returned 10.03%, with a year-to-date return of 6.04%.